Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study

Key facts

Sponsor

University Hospital, Basel, Switzerland

Principal Investigator

Walter P. Weber, Prof. Dr. med.

Department Breast, Abdomen, Pelvis

Intervention

Data Collection from medical records of from an already existing database "ONCOLOGICAL BREAST SURGERY DATABASE OF THE UNIVERSITY HOSPITAL OF BASEL" which was initiated in 2016.(other)

Enrollment

600 enrolled

Eligibility

All sexes

Timeline

2026 – 2027

Study locations (1)

• Department Breast, Abdomen, Pelvis; Universitätsspital Basel, Basel, Switzerland

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Budd-Chiari syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT05782556
  Freiburg TIPS Registry
  University Hospital Freiburg

See all trials for Budd-Chiari syndrome →